Dianthus Therapeutics (DNTH) Equity Ratio (2017 - 2025)
Dianthus Therapeutics (DNTH) has 7 years of Equity Ratio data on record, last reported at 0.95 in Q3 2025.
- For Q3 2025, Equity Ratio fell 0.79% year-over-year to 0.95; the TTM value through Sep 2025 reached 0.95, down 0.79%, while the annual FY2024 figure was 0.94, 0.12% changed from the prior year.
- Equity Ratio reached 0.95 in Q3 2025 per DNTH's latest filing, up from 0.93 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.97 in Q1 2024 and bottomed at 0.78 in Q2 2023.
- Average Equity Ratio over 4 years is 0.41, with a median of 0.93 recorded in 2025.
- The widest YoY moves for Equity Ratio: up 537.69% in 2023, down 436.55% in 2023.
- A 4-year view of Equity Ratio shows it stood at 0.53 in 2022, then surged by 276.32% to 0.94 in 2023, then rose by 0.12% to 0.94 in 2024, then grew by 0.41% to 0.95 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.95 in Q3 2025, 0.93 in Q2 2025, and 0.94 in Q1 2025.